Literature DB >> 12779007

Possible role of matriptase in the diagnosis of ovarian cancer.

Michael D Johnson1, Michael D Oberst, Chen-Yong Lin, Robert B Dickson.   

Abstract

There are increasing data that suggest a role for the serine protease matriptase and its inhibitor, hepatocyte growth factor activator inhibitor-1, in the pathogenesis and progression of ovarian cancer. This review will discuss the matriptase/inhibitor system in the context of ovarian cancer and examine the possibility that this system might be a useful therapeutic and/or diagnostic target in this disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12779007     DOI： 10.1586/14737159.3.3.331

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


  7 in total

1.  Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.

Authors:  Lei Zeng; Jiang Cao; Xing Zhang
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

2.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway.

Authors:  Ami S Bhatt; Alana Welm; Christopher J Farady; Maximiliano Vásquez; Keith Wilson; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

3.  Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.

Authors:  Roman Szabo; Sarah Netzel-Arnett; John P Hobson; Toni M Antalis; Thomas H Bugge
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

Review 5.  Cell surface-anchored serine proteases in cancer progression and metastasis.

Authors:  Carly E Martin; Karin List
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

6.  The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.

Authors:  Lotte K Vogel; Mona Saebø; Camilla F Skjelbred; Kathrine Abell; Esben D K Pedersen; Ulla Vogel; Elin H Kure
Journal:  BMC Cancer       Date:  2006-07-04       Impact factor: 4.430

7.  Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.

Authors:  K U Sales; S Friis; J E Konkel; S Godiksen; M Hatakeyama; K K Hansen; S R Rogatto; R Szabo; L K Vogel; W Chen; J S Gutkind; T H Bugge
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.